Latest Articles

  • Dexamethasone or hydrocortisone in COVID-19?
    Chia Siang Kow and Syed Shahzad Hasan
    Cleveland Clinic Journal of Medicine December 2020, 87 (12) 715; DOI: https://doi.org/10.3949/ccjm.87c.12005

    Dexamethasone should be favored over hydrocortisone.

  • 2020: A year like no other
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine December 2020, 87 (12) 710-711; DOI: https://doi.org/10.3949/ccjm.87b.12020

    Veracity and bias are issues we address on a daily basis.

  • Acute pancreatitis secondary to hypertriglyceridemia
    Michael A. Munoz, MD, Kaviya Sathyakumar, MD and Benson A. Babu, MD, MBA
    Cleveland Clinic Journal of Medicine December 2020, 87 (12) 742-750; DOI: https://doi.org/10.3949/ccjm.87a.19156

    A man presents with acute severe abdominal pain and triglycerides 5,250 mg/dL.

  • Is regular oxygen supplementation safe for obese postoperative patients?
    Roop Kaw, MD and Anthony G. Doufas, MD, PhD
    Cleveland Clinic Journal of Medicine December 2020, 87 (12) 723-727; DOI: https://doi.org/10.3949/ccjm.87a.19051

    Caution for some, but no evidence to support withholding it altogether.

  • In Reply: Assessing stable coronaryartery disease
    Vinayak Nagaraja, MD and A. Michael Lincoff, MD
    Cleveland Clinic Journal of Medicine December 2020, 87 (12) 714; DOI: https://doi.org/10.3949/ccjm.87c.12004

    CT angiography is the appropriate test to exclude left main disease.

  • Air embolism after peripheral IV contrast injection
    Justin Goodwin, MS and Karthik Gnanapandithan, MD, MS, FHM
    Cleveland Clinic Journal of Medicine December 2020, 87 (12) 718-720; DOI: https://doi.org/10.3949/ccjm.87a.20001

    As little as 2 to 3 mL of air in the cerebral circulation can be fatal.

  • In Reply: COVID-19 coagulopathy
    Simon R. Mucha, MD, Siddharth Dugar, MD, Keith McCrae, MD, Douglas Joseph, DO, John Bartholomew, MD, Gretchen L. Sacha, PharmD, RPh, BCCCP and Michael Militello, PharmD, RPh, BCPS
    Cleveland Clinic Journal of Medicine December 2020, 87 (12) 712; DOI: https://doi.org/10.3949/cjm.87c.12002

    An attempt to balance the potential risks and benefits of intensified prophylaxis.

  • Fever in a lung transplant recipient
    Graham Walter, MD, Hanna Lyubetska, MD, MSc and Aditya Sharma, MD, FRCPC
    Cleveland Clinic Journal of Medicine December 2020, 87 (12) 735-741; DOI: https://doi.org/10.3949/ccjm.87a.19132

    A 36-year-old woman presents with high fevers, chills, nausea, decreased oral intake, and diarrhea.

  • Neurologic complications of COVID-19
    Catherine E. Hassett, DO, Aron Gedansky, MD, Ibrahim Migdady, MD, Adarsh Bhimraj, MD, Ken Uchino, MD and Sung-Min Cho, DO
    Cleveland Clinic Journal of Medicine December 2020, 87 (12) 729-734; DOI: https://doi.org/10.3949/ccjm.87a.ccc058

    Human coronaviruses, including SARS-CoV-2, can be neurotropic.

  • COVID-19 coagulopathy
    Anup Katyal, MD
    Cleveland Clinic Journal of Medicine December 2020, 87 (12) 712; DOI: https://doi.org/10.3949/ccjm.87c.12001

    Skepticism of high-intensity prophylaxis for patients with D-dimer ≥ 3.0 µg/mL.

Pages